• AIM: To assess helper T (Th) lymphocyte subset balance in patients with Vogt-Koyanagi-Harada (VKH) disease.
INTRODUCTION
V ogt-Koyanagi-Harada (VKH) disease is one of the most common entities of uveitis in China and now is considered as an autoimmune disease. VKH disease is a kind of granulomatous panuveitis with systemic manifestations consisted of alopecia, vitiligo, poliosis and auditory/central nervous system symptoms [1] [2] . Although a large number of researches have been performed, the exact mechanism of how VKH disease is onset and develop is now still not completely elucidated. Results of former investigations indicated that CD4 + helper T (Th) cells are involved in the occurrence of VKH disease [3] [4] . Traditionally the CD4 + Th cells are considered to be subdivided into two subpopulations, Th1 and Th2, based on their cytokines production. Th1 cells synthesize interferon-γ (IFN-γ) and interleukin (IL)-2, however Th2 cells express IL-4, IL-10 and IL-5 [5] . In classical immune theory the maintenance of a stable immune system depends on the balance of Th1 and Th2 cells [6] [7] . Lately, CD4 + CD25 + regulatory T (Treg) cells and Th17 cells have been found as two entirely different subpopulations from Th1 and Th2 cells. Th17 cells express retinoic acid-related orphan receptor γt (RORγt), however Treg cells produce fork head/winged helix transcription factor (Foxp3). Th17 cells act critical roles during the process of allergic and autoimmunity responses mainly through synthesizing IL-17, while Treg cells' function is anti-inflammatory and keeping tolerance to self-antigens via producing IL-10 or by contact-dependent suppression [8] . The balance between Treg and Th17 together with Th1 and Th2 lymphocytes may thus play a key role in the process of autoimmune and inflammatory diseases [9] . The purposes of this research were investigating the Th lymphocyte subset balance in patients with VKH and assess whether it is associated with disease activity.
SUBJECTS AND METHODS Ethical Approval
This research was consented by the Tongren Hospital Science and Ethics Committee. All operations satisfied the dogmas of the Declaration of Helsinki. The informed consents were collected from each of the healthy controls and VKH patients. Ethical registration number: ChiCTR1800016183. Subjects In total sixty-eight patients with active VKH and seventy-two patients with inactive VKH were included in this study. One hundred healthy individuals were enrolled as a control group. All the subjects were enrolled between March 2009 and May 2015 at the uveitis clinic of the Tongren Eye Center. VKH patients were diagnosed based on the diagnostic criteria made by an international committee [10] . Plasma Cytokine Levels in Vogt-Koyanagi-Harada Active VKH patients showed significant higher levels of cytokines related with Th17 (TGF-β, IL-6, IL-23, and IL-17) and an obvious lower level of cytokines related with Treg (IL-10) as compared with inactive VKH patients and healthy controls. Inactive VKH patients showed no differences in peripheral Th17 related cytokines (TGF-β, IL-6, IL-23, and IL-17) and Treg related cytokine (IL-10) plasma levels as compared with healthy controls. Compared with inactive VKH patients, the VKH patients with active uveitis had noticeably higher plasma levels of cytokines related with Th17 (IL-6, IL-17, IL-23, and TGF-β) and lower levels of cytokines related with Treg (IL-10; Table 3 ). DISCUSSION This study shows that disease activity in VKH disease is related with a significant increase in the circulating proinflammatory Th1 and Th17 lymphocyte subpopulations and a concomitant decrease in the Treg subset. Similar alterations were observed in the signature cytokines of these lymphocyte subsets indicating a role for an imbalanced systemic immune system in the development of VKH disease. Our study confirms and extends earlier findings from our group showing an increased production of IL-17 of CD4 positive T cells and PBMCs from active VKH patients treated with anti-CD28 and anti-CD3 antibodies [11] . We also reported that IFN-γ, IL-17 and RORγt were increased in active VKH patients and that cyclosporin A and corticosteroids could decrease these elevated cytokines levels which were related with the clinical relief of the uveitis [12] . It has been showed that cyclosporin A and dexamethasone could reduce Th1 and Th17 cells frequencies and decrease the IL-17 or IFN-γ release. All these results indicate that an increased response of Th17 and Th1 is related to active VKH disease and that corticosteroids and cyclosporin A may execute their immunosuppressive role by decreasing Th17 and Th1 cells. Studies from various laboratories have now shown that the Th17 subset exerts a key role in the development of various autoimmune diseases by mainly producing IL-17 [13] [14] . It has been proved that IL-17 acts as a proinflammatory factor in vitro and vivo by inducing the expression of chemokines (such as monocyte chemotactic protein-1) and cytokines (such as TNF-α and IL-6) [15] . It has also been observed that the IL-17 level was increased in many autoimmune diseases such as multiple sclerosis [16] , rheumatoid arthritis [17] and inflammatory bowel disease [18] , indicating that IL-17 may act a critical role in the development of these diseases. Furthermore, in IL-17-/-mice collagen induced arthritis and experimental autoimmune encephalomyelitis, the animal models for rheumatoid arthritis and multiple sclerosis, respectively, could not be induced [19] [20] . Thus, there is a strong possibility that Th17 cells are involved in autoimmunity and that targeting these cells may provide an attractive option for immunotherapy of these diseases. It has also been proved that CD4 + CD25 + Foxp3 + Treg cells could effectively suppress the development of autoimmune disease [8] . In many autoimmune diseases, decreased number of Treg cells has been observed [21] [22] [23] [24] , and several autoimmune disorders have been shown to be relieved by adoptive transfer of purified Treg cells [25] [26] [27] [28] . One study has demonstrated that in patients with active VKH Treg frequencies and functional properties were decreased [29] . Th17/Treg functional imbalance has also been found existed in atherosclerosis. In this study, we found that Treg cells frequencies were significantly lower in VKH patients with active uveitis as compared with healthy controls and inactive VKH patients. These findings confirm the hypothesis that Treg cells have a potential protective effect in the pathogenesis of VKH. Treg cells perform their anti-inflammatory function mainly by expressing IL-10. In this study, the results showed that the level of IL-10 in plasma was decreased in active VKH, suggesting that IL-10 may exert a protective role in this disease. A limitation of our study is that we studied only four subsets of Th lymphocyte. There are other subsets in Th lymphocyte such as Th9, Th22 and Tfh. Further investigations are needed to elucidate the changes of other subsets of Th lymphocyte. In summary, our data show a dysfunctional lymphocyte subset balance in patients with VKH and suggest that lymphocyte subset analysis might be used as a disease marker.
